Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
about
Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor-tyrosine kinase inhibitors.Abnormalities of signal transduction networks in chronic schizophrenia.Epidermal growth factor receptor expression affects proliferation and apoptosis in non-small cell lung cancer cells via the extracellular signal-regulated kinase/microRNA 200a signaling pathway.Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation
P2860
Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Polymorphisms in epidermal gro ...... FR tyrosine kinase inhibitors.
@en
type
label
Polymorphisms in epidermal gro ...... FR tyrosine kinase inhibitors.
@en
prefLabel
Polymorphisms in epidermal gro ...... FR tyrosine kinase inhibitors.
@en
P2093
P2860
P1433
P1476
Polymorphisms in epidermal gro ...... FR tyrosine kinase inhibitors.
@en
P2093
Junwei Fan
Shengtao Lin
Shengying Qin
Xiaoqing Zhang
Zhemin Zhang
P2860
P2888
P304
P356
10.1007/S13277-015-3893-1
P577
2015-08-14T00:00:00Z
P6179
1025809073